24 May 2013
Keywords: Galapagos, Ono Pharma, BioFocus, CNS drug discovery
Article | 03 September 2012
Belgian biotech firm Galapagos NV (Euronext: GLPG) says that its service division BioFocus and Japanese drugmaker Ono Pharmaceutical (TYO: 4528) have ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 September 2012
4 September 2012
© 2013 thepharmaletter.com